Skip to main content
. 2011 Mar 21;34(4):828–837. doi: 10.2337/dc10-1233

Figure 1.

Figure 1

Mean (95% CI) percentage change from baseline in HOMA-IR (ITT population, last observation carried forward) and change from baseline in HbA1c (ITT population, study completers) among all patients (A and D), patients with type 2 diabetes (B and E), and patients with MetS (C and F). P values reported for comparisons between groups.